These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9243618)
61. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides. Filla SA; Mathes BM; Johnson KW; Phebus LA; Cohen ML; Nelson DL; Zgombick JM; Erickson JA; Schenck KW; Wainscott DB; Branchek TA; Schaus JM J Med Chem; 2003 Jul; 46(14):3060-71. PubMed ID: 12825944 [TBL] [Abstract][Full Text] [Related]
62. Humanization of mouse 5-hydroxytryptamine1B receptor gene by homologous recombination: in vitro and in vivo characterization. Bonaventure P; Umans L; Bakker MH; Cras P; Langlois X; Luyten WH; Megens AA; Serneels L; Van Leuven F; Leysen JE Mol Pharmacol; 1999 Jul; 56(1):54-67. PubMed ID: 10385684 [TBL] [Abstract][Full Text] [Related]
63. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Hoskin KL; Lambert GA; Donaldson C; Zagami AS Brain Res; 2004 Feb; 998(1):91-9. PubMed ID: 14725972 [TBL] [Abstract][Full Text] [Related]
64. Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan. Miller KJ; King A; Demchyshyn L; Niznik H; Teitler M Eur J Pharmacol; 1992 Sep; 227(1):99-102. PubMed ID: 1330643 [TBL] [Abstract][Full Text] [Related]
65. 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists. Slassi A; Edwards L; O'Brien A; Meng CQ; Xin T; Seto C; Lee DK; MacLean N; Hynd D; Chen C; Wang H; Kamboj R; Rakhit S Bioorg Med Chem Lett; 2000 Aug; 10(15):1707-9. PubMed ID: 10937729 [TBL] [Abstract][Full Text] [Related]
66. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle. Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490 [TBL] [Abstract][Full Text] [Related]
67. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor. Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663 [TBL] [Abstract][Full Text] [Related]
68. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124 [TBL] [Abstract][Full Text] [Related]
69. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663 [TBL] [Abstract][Full Text] [Related]
71. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans. Classey JD; Bartsch T; Goadsby PJ Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155 [TBL] [Abstract][Full Text] [Related]
73. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development. Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158 [TBL] [Abstract][Full Text] [Related]
74. The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Cumberbatch MJ; Hill RG; Hargreaves RJ Eur J Pharmacol; 1998 Nov; 362(1):43-6. PubMed ID: 9865528 [TBL] [Abstract][Full Text] [Related]
75. Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Rebeck GW; Maynard KI; Hyman BT; Moskowitz MA Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3666-9. PubMed ID: 8170966 [TBL] [Abstract][Full Text] [Related]
76. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide. Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369 [TBL] [Abstract][Full Text] [Related]
77. Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea pig proximal colon in vitro? Sevcík J; Ruzicka V; Slánsky J; Masek K Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):421-30. PubMed ID: 8900213 [TBL] [Abstract][Full Text] [Related]
78. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Ellwood AJ; Curtis MJ Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503 [TBL] [Abstract][Full Text] [Related]
79. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Goadsby PJ; Classey JD Neuroscience; 2003; 122(2):491-8. PubMed ID: 14614913 [TBL] [Abstract][Full Text] [Related]
80. Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11. Huang Z; Byun B; Matsubara T; Moskowitz MA Br J Pharmacol; 1993 Feb; 108(2):331-5. PubMed ID: 8383561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]